Characteristics
|
A potent inhibitor of mammalian histone deacetylases (HDACs) (IC50= 15.7 nM). A novel antitumor agent, oxamflatin modifies epigenetic status and gene expression, increases blastocyst quality, and subsequently enhances the nuclear reprogramming and developmental potential of SCNT (somatic cell nuclear transfer) embryos.
|